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ABSTRACT
Background: Hypertension, being a very prominent disease, is a common problem found
during urgent care visits. By beginning in the urgent care setting, hypertension
management can be started early; thereby preventing complications from uncontrolled
hypertension.
Purpose: This DNP project aimed to improve patient knowledge of hypertension and
overall blood pressure readings by providing one-to-one provider-patient education.
Design Method: This DNP quality improvement project was a pre- and post-test design
using quantitative data. The goal was to access if there was a change in patient education
pre, post, and three months follow-up along with a change in blood pressure.
Results: This DNP project demonstrated a statistically significant improvement in both
hypertension knowledge and blood pressure measurements.
Conclusion: Urgent care centers frequently observe individuals with no primary care
providers and undiagnosed hypertension. More structured one-to-one provider-patient
education along with handouts were needed to help decrease and manage hypertension.
Implications for Nursing: Education beginning in the urgent care setting for individuals
without a primary care provider and meeting criteria for hypertension can result in a
positive outcome for patients.
Keywords: hypertension, hypertension management, urgent care, hypertension education,
blood pressure, provider education, hypertension clinical practice guidelines
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Hypertension Education and Management Intervention (HEMI)
in the Urgent Care Setting

Introduction
Urgent care centers allow access to primary care, and bridge the gap between
primary care and emergency services (Katz, 2019). With many urgent care centers
assisting with acute injuries and illnesses, often hypertension is overlooked in patients
utilizing these services. Hypertension is defined as systolic blood pressure (SBP) greater
than or equal to 130 or diastolic blood pressure (DBP) greater than or equal to 80
(American Heart Association, 2020). Hypertension can affect anyone and can have
lasting effects on the body. According to the Center of Disease Control and Prevention
National Center for Health Statistics, the prevalence of hypertension in adults 18 years of
age and older is 29% (CDC, 2020). With the prevalence increasing among the general
population, certain groups are at an increased risk. Prevalence increases with age.
Individuals ages 18-39 years account for 7.5%, those age 40-59 make up 32.2%, and the
rates in age 60 and older is an astounding 63.1% (Fryar, Ostchega, Hales, Zhang, &
Kruszon-Moran, 2017). In addition to age affecting prevalence, gender and race also
contribute to hypertension. Men have a higher prevalence of hypertension than females,
and non-Hispanic African Americans have higher prevalence when compared to nonHispanic Caucasian, non-Hispanic Asian, and Hispanic adults (Samanic et al., 2020).
Many times people are unaware they have hypertension and have little to no side
effects related to current blood pressure readings. Hypertension can be easily treated with
lifestyle modification and medication compliance, starting in an urgent care setting and
1

continuing into primary care. Initiating hypertension treatment in the urgent care setting
will help to decrease healthcare costs for both patients and healthcare organizations by
decreasing the long-term complications from uncontrolled hypertension. Providing an
educational intervention for hypertension management early in the urgent care setting
will allow patients to have healthier lives and decrease the costs of associated healthrelated problems.
Background
Urgent care centers have consistently grown since their emergence in the 1980s,
and currently over 7,000 exist, providing healthcare access to more than 160 million
patients annually (Ashton, 2017). Urgent care centers offer medical services for acute
illnesses and injuries when emergency services such as the emergency room are not
warranted. Most urgent care centers operate on a walk-in basis and are located in
convenient locations to homes or workplaces. Many urgent care center providers see
individuals in rural and urban areas who do not have primary care providers.
The Center for Disease Control and Prevention (CDC) indicated that 108 million
or 45% of adults in the United States have a diagnosis of hypertension (CDC, 2020). Of
the 108 million, nearly one-third, 30 million adults are not prescribed or are not taking
medication for hypertension management (CDC, 2020). Uncontrolled hypertension place
individuals at higher risks of health complications, including heart disease and stroke,
which are the leading causes of death in the United States. In addition to increasing health
risks, hypertension is the primary cause of death of 472,000 individuals yearly and costs
$131 billion each year (CDC, 2020).
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Hypertension has different stages that guide practice and recommendations for
initiation of lifestyle modifications and/or medications. The stages for hypertension are:
•

Normal SBP less than 120mmHg and DBP less than 80mmHg

•

Elevated SBP 120-129mmHg and DBP less than 80mmHg

•

Stage 1 hypertension SBP 130-139mmHg and DBP 80-90mmHg

•

Stage 2 hypertension SBP greater than or equal to 140mmHg and DBP
greater than or equal to 90mmHg (American Heart Association, 2020).

For a patient to receive the diagnosis of hypertension, there should be two separate
readings of blood pressure, with the highest one determining which category the patient
would be in. The readings can be two separate office visits or one office visit and one
reading from an outside office or another provider.
Barriers to healthcare can affect why people have undiagnosed hypertension or
poorly controlled hypertension. Barriers that exist in healthcare are geographical barriers,
long wait times and decreased access to care, lack of affordable healthcare, and a
decreased number of available healthcare professionals (Standford, 2020). Urgent care
centers located in geographically accessible areas promote access to care for patients;
thereby, improving uncontrolled hypertension, resulting in better management of the
disease process (Obuyama et al., 2019). Having access to care is an essential factor for
the management of hypertension and can improve outcomes (Obuyama et al., 2019).
Additionally, affordable healthcare allows patients to seek care when needed without
financial concerns. Lastly, the shortage of healthcare providers causes strain to all by
increasing wait times and an inability to provide quality healthcare for patients.
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Problem Statement
Individuals who have pre-hypertension/hypertension (systolic blood pressure
greater than or equal to 130 or diastolic blood pressure greater than or equal to 80) should
be given one-to-one provider-patient education and started on hypertension treatment.
Providing education to patients and beginning treatment will increase the patient’s
knowledge level and should result in decreased blood pressure at the three-month followup appointment. The PICOT question for this DNP project was: P - individuals who have
pre-hypertension/hypertension (systolic blood pressure greater than or equal to 130 or a
diastolic blood pressure greater than or equal to 80); I - one-to-one provider-patient
education, provider education, and medication management; C - compared to no
education or medication management; O - increase patient’s knowledge and decrease
blood pressure; and T - at a three-month follow-up appointment.
This DNP Quality Improvement Project is focused on both a clinical and
education problem. The clinical portion of this project is to diagnosis and treat
undiagnosed patients with pre-hypertension/hypertension. The educational portion of this
project will foster a two-pronged approach. First, patient education to manage
hypertension and second, provider education about teaching topics, assessing labs, and
follow-up appointments.
Organizational Description of Project Site
This project will assist individuals who do not have primary care providers or are
unable to get into primary care providers’ offices due to demand and shortages. Since
many are unable to get into a primary care provider’s office, individuals turn to urgent
care for treatment options. The setting of this DNP project will be in an outpatient urgent
4

care center located in the Birmingham, Alabama, a metropolitan area with a median
household income of $142,221 (DataUSA, 2021). The urgent care center sees around
12,000 patients annually for acute illnesses and injuries as well as to offering primary
care services.

Review of the Literature
Urgent care centers have 89 million visits per year for acute injuries, illness, and
primary care (Dolan, 2019). The high volumes of visits are related to patients being
unable to get into primary care offices or not having a primary care provider. Many times
during urgent care visits underlying conditions, such as hypertension, are found, and
treatment is delayed/deferred to primary care providers. Urgent care clinics are affordable
options for individuals and allow treatment to be given sooner rather than later (Katz,
2019).
Hypertension is a health problem occurring in 45% of the United States
population (CDC, 2020). Hypertension is systolic blood pressure greater than or equal to
130 or diastolic blood pressure greater than or equal to 90 (Reboussin et al., 2017).
Untreated and uncontrolled hypertension can lead to severe health disparities including
cardiovascular disease, stroke, chronic kidney disease, and ultimately death (Ebrahim &
Hassan, 2018). Healthcare providers who recognize and begin treatment can facilitate
improvement in health outcomes for patients and prevent complications from other health
disparities.
Many times, urgent care providers are not routinely up to date with the newest
primary care and hypertension guidelines and recommendations, and are unsure what
5

should warrant treatment, what should be checked/how often (labs), which medication
would be best for the patient, and how long before a patient should follow-up. By
following protocols and guidelines issued, providers would begin a journey to better
control this silent killer (Satish, Khetan, Raithatha, Bhende, & Josephson, 2019). While
guiding treatment options, a protocol provides a standardized plan for patient education
that would assist providers in the communication of hypertension education. Scholars
have found that communication skills are a critical component associated with
improvement in hypertension outcomes (Tavakoly-Sany et al., 2018). With the
prevalence of hypertension increasing each year, it is essential to understand the barriers
between patients.
Gebrezgi, Trepka, and Kidane (2017) conducted a qualitative study using
interviews of 48 participants diagnosed with hypertension to learn more about the barriers
patients faced. Participant follow-up occurred every three months and patients received
provider counseling each time. Participant interviews consisted of pre- and post-interview
close-ended questions about demographic information and open-ended questions related
to the awareness and practice of the participants regarding hypertension management.
Participants were asked about their experiences living with hypertension, knowledge of
hypertension, perception of the principles of hypertension management, the practice of
lifestyle modification, barriers, and facilitators to hypertension management. The findings
of this study demonstrated participants had a good understanding of what was needed
regarding adherence to medication, salt consumption reduction, physical activity, diet
control, and lowering of alcohol consumption. Also, this study found that counseling
patients about care with appropriate physical activity as well as how to adhere to diet
6

recommendations with affordable food choices could potentially increase their adherence
to the principles of hypertension management. (Gebrezgi et al., 2017). Barriers that were
identified included: adherence to medication, sodium consumption reduction, physical
activity, diet control, and lowering alcohol consumption (Gebrezgi et al., 2017).
Understanding these barriers increased adherence and understanding of self-care
practices; thus, enhancing patient education (Gebrezgi et al., 2017).
In a study by Worku et al. (2020), 385 adult hypertensive patients were assessed
on their knowledge of hypertension and self-care practices. The study utilized a crosssectional study design at the University of Gondar Comprehensive Specialized Hospital
from April 2019 to May 2019. Participants were given a Hypertension Self-Care Activity
Level Effects (H-SCALE) assessment to measure knowledge of effects of hypertension.
The H-SCALE is a validation tool for patients with hypertension to measure their
knowledge on self-care related to hypertension. When participants scored median or
above, the participants were knowledgeable of hypertension topics. If participants scored
below median, they were uninformed of hypertension topics. Study findings showed that
365 (92.4%) of participants reported knowing hypertension was a serious disease and 379
(98.7%) of participants indicated that regular check-ups were essential. However, 133
(37.5%) were not aware of the normal blood pressure level. Two hundred fifteen (56%)
participants scoring median and above were considered to have good knowledge about
hypertension, while 169 (44%) scored below median and were considered to have a poor
understanding of hypertension. In regard to self-care, 228 (59.4%) participants had
acceptable self-care practices, while 156 (40.6%) had poor self-care. Of the self-care
practices, 261 (68%) reported medication adherence, 266 (69.3%) maintained a low
7

sodium diet, and 81 (21.1%) participated in physical activity. In the cross-tabulation of
self-care practices with knowledge level, a higher frequency of good self-care practices
was observed among those with good hypertension knowledge. This study demonstrated
that focusing on and increasing awareness of hypertension and self-management of
hypertension was essential (Worku et al., 2020).
Many patients seek care in an urgent care setting, either in an outpatient clinic or
emergency department, for some other form of illness. Still, while being there, patients
are told they have asymptomatic hypertension and to follow up with their primary care
provider. Winders et al. (2018) examined how many patients received discharge
paperwork. To be eligible to participate in this study, patients were 18 years of age or
older, assigned an Emergency Service Index (ESI) triage acuity of 3 or greater, and had a
recorded SBP greater than or equal to 160 mmHg or DBP greater than or equal to 100
mmHg. Of the 2,504 patients discharged from the emergency department, 974 met the
criteria of elevated blood pressure, 200 were successfully contacted, and 90 provided
consent to participate in the study (Winders et al., 2018).
Winders et al. (2018) found that 90 patients (66%) were informed of an elevated
blood pressure reading; however, only 3-5 patients received hypertension-specific written
discharge instructions from a provider. The lack of discharge instructions given to
patients led to 51 (57%) patients following up with a primary care provider within a 2- to
4-week time period after discharge. Less than 10% of patients who did receive
hypertension education at discharge were consistent with previous studies demonstrating
a lack of patient education occurring at discharge; this contributed to up to 90% of
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emergency room providers not recognizing hypertension or providing proper education
(Winders et al., 2018).
Providers recognizing and starting treatment of hypertension early in urgent care
settings will lead to better health outcomes for patients. According to Volpe, Gallo, and
Tocci (2018), patients who have uncontrolled or undiagnosed hypertension were at more
significant risk for development of myocardial infarction, stroke, heart failure, CV, and
all-cause mortality. This study demonstrated that starting blood pressure medication early
and fast prevented major events in patients. Around 60% of patients who have prehypertension (SBP 120-139 mmHg or DBP 80-90 mmHg) or high normal (130-139/8590 mmHg) will develop hypertension within four years compared to a blood pressure
value less than or equal to 120/80 mmHg. Initiating medications in this group of
individuals decreased CV risks by providing a protective effect. Medication implemented
early or at pre-hypertension or normal high hypertension stages can prevent the
progression to hypertension and decrease the risk of significant events occurring as
quickly (Volpe et al., 2018).
Patients with hypertension need to understand associated risks; however, it is the
responsibility of providers to ensure patients understand. According to Tavakoly et al.,
(2018), communication from providers can affect hypertension outcomes. Hypertension
has continued to increase in the Iranian population, making it a significant risk factor
with cardiovascular mortality and morbidity. A simple random sampling of 35 out of 108
healthcare providers at the Ministry of Health were enrolled in the study, and 240 out of
940 patients were enrolled. Inclusion criteria for patients included (a) high blood
pressure, (b) age 18 or older, (c) prescribed at least one anti-hypertension medication
9

during the last three months, and (d) could read and write their native language.
Exclusion criteria were (a) unable to give informed consent, (b) were affected by renal
disease, or (c) had a mental disturbance, visual impairment, or upper extremity limb
disability. Patients completed Health Literacy Assessment Questions (HLAQ) during
their routine provider office visit. The HLAQ is a tool that assesses provider
communication. After the initial office visit, the providers who participated in this study
attended three sessions of focused-group discussions and two training sessions focusing
on educational interventions. After the training had been completed for providers, the
patients (of the providers) would complete HLAQs at their next office visit. The HLAQs
found that 63.4% of patients need more support from their providers, along with 52% of
patients rating their provider’s communication to be non-collaborative. This study found
that improvement of provider communication skills are associated with improvement in
hypertension outcomes. By providers being taught and having specific training and
understanding on specific topics that need further addressing allowed for patients to have
a better understanding and management of hypertension (Tavakoly et al., 2018).
Petersen et al. (2020) postulated that many people live for a long time, unaware
they have high blood pressure. The study Know Your Heart (KYH) was a cross-sectional
study of cardiovascular structure, function, and risk factors in over 2,353 men and women
aged 35-69 years. The study focused on three different stages: background interview,
health check, and repeat health check. The blood pressure was measured with an
OMRON 705 IT automatic blood pressure monitor, which was calibrated before utilizing
it. Participants were then assigned two different categories based upon their systolic and
diastolic blood pressure using the European hypertension guidelines. The thresholds for
10

this study were a SBP of 140 mmHg or more and a DBP of 90 mmHg or more. Three
hundred thirty-two participants were asked to come back one year later for repeat
measurements. Of the 332 participants returning, prevalence of untreated hypertension
was 51.1% for males, 28.8% for females, and 40% overall. This study confirms that a
relatively high prevalence of untreated hypertension occurs daily and is not treated.
Initiatives are needed to strengthen the education of primary care providers to ensure
hypertension management is initiated early and without delay of treatment (Petersen et
al., 2020).
Delavar, Pashaeypoor, and Negarandeh (2020) conducted a randomized
controlled trial from January to March 2018. The study population was comprised of
older adult patients with uncontrolled primary hypertension and inadequate health
literacy. Eligibility for the study included a diagnosis of uncontrolled hypertension, age
of 60 or greater, as well as, no diagnosis of drug addiction, dementia, or psychiatric
disorder. Three hundred fifty-three patients were referred to the study, and 118 patients
were selected to participate and divided into subgroups consisting of 59 people. Primary
and secondary outcomes were then measured. Primary results were the patient's blood
pressure readings at the beginning, and secondary outcomes were taken six weeks after.
The Morisky Medication Adherence Scale was used for adherence to medication. One
subgroup was given self-medication education that was tailored to their health literacy
after the initial visit and questionnaire. The Chi-square showed no significance between
groups' demographic status. The results did show that there was a significant reduction of
the systolic and diastolic blood pressure. In addition, medication adherence in both the
control and intervention groups was poor prior to interventions. After the intervention,
11

the medication adherence status in the intervention group was significantly better than the
control group. The findings of this study show that providing self-medication education
to patients at the level of their health literacy can significantly promote medication
adherence and decrease both SBP and DBP among older adult patients diagnosed with
uncontrolled hypertension (Delavar et al., 2020).
Sung, Lai, Wu, and Hsieh (2017) discovered the incidence of stroke had been
decreasing in Taiwan due to the increased use of anti-diabetic, antihypertensive, and
lipid-lowering medications. This study consisted of all adult patients age 20 years and
older between 2000 and 2013 with a principal discharge diagnosis of stroke, ischemic
stroke, and intracerebral hemorrhage. The study consisted of two subgroups; the first was
the un-diagnosed subgroup who had never been diagnosed with vascular risk factors
(VRF) (hypertension, hyperlipidemia, and diabetes). The second subgroup was patients
who had been diagnosed with a VRF within the past year at least one time. The study
consisted of 16,301 adults with the first-ever stroke, of which 12,323 were ischemic
strokes, and 3,978 were intracerebral hemorrhage. Of the 16,301 patients that were
participating in the study, an astonishing 9,722 of the patients were diagnosed with
hypertension during admission; however, only 5,447 patients had a pre-existing diagnosis
of hypertension. The study found that there was generally an inverse association between
age and prevalence of prior undiagnosed VRF with the first-ever stoke. It was also found
that younger patients were more likely to be non-adherent to antihypertensive
medications within one year prior to stroke compared to patients with a pre-existing
history. This study shows the treatment of hypertension is of utmost importance in the
prevention of stroke regardless of patients' age. Patients who were previously
12

undiagnosed with hypertension and had nonadherence to treatment for hypertension were
more prevalent in young adults with the first-ever stroke in Taiwan. Interventions
targeting younger people to promote early detection and adequate control of VRF should
be encouraged for the primary prevention of stroke and other complications (Sung, Lai et
al., 2017).
Johnson, Warner, Bartels, and LaMantia (2017) postulated young adults, 18 to 39
years of age, have the lowest hypertension control rates among any group in the United
States. This study was approved by the University of Wisconsin-Madison Health Science
Institutional Review Board. The study found that barriers exist with young adults and
starting hypertension medication. The researchers conducted one-to-one interviews with
15 providers (physicians and nurse practitioners) from three different family
medicine/family practice clinics within three different counties in Wisconsin. All
providers felt the Joint National Committee 8 (JNC 8) guidelines were applicable to
young adults the same as middle-aged and older adults. Providers all had similar
responses to transitioning young adults to the next stage of hypertension management.
Providers also felt by diagnosing hypertension in young adults, resulted in a ‘sick
identity’, meaning more frequent returns to the clinic and waiting in rooms with older
adults. All of this leads to resistance to achieving hypertension control. Another finding
from the provider’s interview was the concern for a false hypertension diagnosis. Many
providers felt providing a diagnosis too early could cause problems. In many instances,
the provider was concerned about the blood pressure variability from reversible causes
(stress, white coat syndrome, caffeine, alcohol, or tobacco use) (Johnson et al., 2017).
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Johnson et al. (2017) conveyed, the providers who were interviewed for this study
were reluctant to start medication on younger adults due to younger adults being hesitant
to make a lifelong commitment with medications, and many times, the ‘no show’ rates
for younger adults were higher. In addition, gender played a big role in follow-up, with
males having higher ‘no shows’ compared to females who may return for other
medications to be filled, such as birth control. Overall, this study provides knowledge of
barriers that must be faced by providers to enhance hypertension management.
Traditional hypertension management and care must be changed to deliver ongoing blood
pressure self-management in younger adults (Johnson et al., 2017).
Shrestha et al. (2018) suggested that hypertension was a significant and rising
burden in Nepal due to the disease being undiagnosed and inadequately managed. This
qualitative study recruited 1,073 patients age 18 and older, of which 321 were
participants with hypertension in the community. One hundred sixty-one patients who
were newly diagnosed with hypertension were given referral cards and asked to go to a
health institution for consultation. The remaining patients who had a history of
hypertension were then divided into four groups based on their treatment and care. The
four groups were:
•

patients who did not seek healthcare at all,

•

those currently on treatment and were compliant with medications,

•

those currently on treatment and not compliant with medications, and
lastly, and

•

those who were measured with high blood pressure in a survey.
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Participants were then predetermined using open-ended guidelines with the domains of
patients' knowledge, attitudes, and practices about hypertension; barriers to healthcare;
and lastly, facilitators to healthcare. These findings found participants were aware that
high blood pressure is common, and numbers were increasing. Participants also showed
knowledge that linked blood pressure to diet and lack of physical activity; however, only
five mentioned hereditary or age as a cause of hypertension. Participants were aware of
the benefits to lifestyle modifications to decrease blood pressure; however, reported it
was hard to practice and incorporate into daily life due to food cravings, food taste,
smoking, and consuming alcohol. Many participants reported that lack of exercise was
due to laziness, along with bus schedule and musculoskeletal pain that limited activities.
All of the groups believed the absence of symptoms meant there was no diagnosis and
reported visiting a practitioner only when symptoms were present (Shrestha et al., 2018).
Shrestha et al., (2018) indicated many who did not seek medical attention after
diagnosis even believed they had hypertension. Many participants did not believe
hypertension was a serious condition and did not seek treatment because it was not
serious. Lastly, many did not seek healthcare after diagnosis due to being reluctant to
initiate medication due to its long-term and associated costs. Treatment and follow-up
findings found fear of consequences, patients' self-awareness, and self-control. Also,
family and social support increase compliance with medications. This study shows newly
diagnosed hypertension patients have inadequate knowledge and misbeliefs regarding
hypertension and its treatments. Ultimately, health interventions improving hypertension
should focus on developing and disseminating appropriate health information with a
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focus on the nature of hypertension, regular medication intake, lifestyle modifications,
and the consequences of poorly managed hypertension (Shrestha et al., 2018).
Rahimdel, Morowatisharifabad, Salehi-Abargouei, Mirzaei, and Fallahzadeh
(2019) endorsed hypertension as accounting for 9.4 million deaths each year, with at least
45% of deaths related to heart disease. Two important behavioral determinants of
hypertension were identified as excessive caloric intake and excessive sodium intake. The
World Health Organization (WHO) recommendations are for adults to consume two
grams of sodium per day; however, in 2010 a study found the average daily intake of
sodium to be 10.06 grams per day. High dietary sodium intake increases blood pressure;
however, the reduction of sodium can reduce systolic and diastolic blood pressure 4-5
mmHg and 1-3 mmHg, respectively. The reduction of sodium is one of the cost-effective
lifestyle modifications to reduce hypertension. In addition, studies have shown that
educational interventions have been effective in reducing sodium intake (Rahimdel et al.,
2019).
Rahimdel et al. (2019) performed randomized controlled trials, utilizing the
theory of planned behavior (TPH), between February 2017 and December 2017, in which
participants who were identified to be at risk of developing hypertension were selected
randomly. Inclusion criteria were being 35 to 50 years of age with a SBP 120-139 mmHg
and DBP 80-89 mmHg, lack of congenital heart disease, and living in Shahediyeh, Yazd
Province, Iran. Exclusion criteria were being on a diet or avoiding certain types of food,
suffering from kidney disease, mental illness, taking anti-hypertension medications,
pregnancy, and lack of providing consent (Rahimdel et al., 2019).
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Rahimdel et al. (2019) indicated, 140 participants were divided into two different
groups, a control group, and an experimental group. Each group completed a pre-test
questionnaire that provided an understanding of hypertension and sodium intake, had
their blood pressure measured, and measurement of sodium and potassium in urine
assessed through a 24-hour urine sample. Afterward, the experimental group received
educational content in booklet form containing information about sodium and the
consumption rates in Iran, the definition of blood pressure, the effects of high sodium
intake, sources of sodium and associated diseases, high sodium foods, the ways of
sodium intake reduction and the amount of sodium in foods. In addition to the
educational booklet, the experimental group attended a total of 10 educational sessions
lasting 90 minutes each time. After two months, all participants returned to complete a
post-questionnaire, measure blood pressure, and complete a 24-hour urine sample. The
findings found the interventional group had behavioral beliefs, outcome evaluation,
attitude, normative beliefs, motivation to comply, subjective normal, control beliefs,
perceived power, and perceived behavior control over sodium intake compared to the
control group. This study justified that utilizing TPH-based education interventions was
effective in reducing sodium intake in individuals at risk for developing hypertension
(Rahimdel et al., 2019).
Jahangeer, Bano, Khan, Qamar, and Adil (2019) posited that hypertension is a
global health risk with far ranking impact on quality of life and its duration. According to
the last national health survey, 18% of Pakistanis 15 years of age or older had a diagnosis
of hypertension. The report demonstrated that only 50% of the population were
diagnosed, and of the affected, only half had access to treatment. Findings further
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indicated that compared to larger countries, the controlled rates of hypertension are not
encouraging, with only 35% achieved in the United States, 24% in Australia, 8% in
China, and 6% in India. Prior to this study, there had been none conducted in Pakistan at
the basic health unit level, which is the baseline healthcare installation of government’s
health department and organizational structure (Jahangeer, et al., 2019).
Jahangeer, et al. (2019) explained the purpose of this study was to identify and
gauge the dynamics of hypertension knowledge and preferences among the rural
population in Pakistan. A cross-sectional study was conducted at the Basic Health Unit
(BHU) Mangat Neecha during a one-month period in 2018 consisting of 143 patients
who had a diagnosis of hypertension in the BHU health records. Questionnaires were
designed based upon existing knowledge and approaches to rural areas. The findings
suggested that 83 participants (58%) of the study did not have knowledge regarding ideal
blood pressure readings for a normal individual. Furthermore, the study proposed that
32.2% of individuals who participated did not know the correct cut-off for normal blood
pressure, and only 19.6% were able to correctly identify SBP and DBP. Positive findings
indicated that 126 (88%) individuals did affirm hypertension posed a significant impact
on their health and 72.7% agreed that having lower blood pressures would significantly
improve quality of life. However, 38 participants (26.6%) did not believe interventions
would make any impact on their blood pressure. Lastly, the study revealed that all
individuals were informed of having high blood pressure from their healthcare provider;
however, only 43 (30.1%) had been informed about what their blood pressure should be,
and 60 (42%) were never informed of individual optimal blood pressure readings
(Jahangeer, et al., 2019).
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The study findings from Jahangeer et al. (2019) suggested inadequate knowledge
and awareness about hypertension present greatly in rural areas. Many rural individuals
do not recognize hypertension as a very serious health concern; therefore, strengthening
the need for extensive education and counseling to improve adherence to medication and
decrease cardiovascular events (Jahangeer, et al., 2019).
According to Owen (2019), hypertension affects a third of all Americans, and
20% have undiagnosed and untreated hypertension. Undiagnosed hypertension increases
the morbidity and mortality of the patient by increasing cardiovascular events and chronic
kidney disease. Often, patients of primary care providers present with elevated blood
pressure measurements, and it remains undiagnosed (Owen, 2019).
Owen (2019) conducted a DNP quality improvement project to determine the
effectiveness of an educational intervention on the rates of diagnosis and treatment of
hypertension in a primary care clinic in Kansas City, Kansas. This DNP project was
created to improve follow-up with individuals at risk for undiagnosed hypertension by
measuring pre-intervention blood pressures, providing education, and comparing postintervention blood pressure readings. For participants to be enrolled in this project, SBP
must be greater than equal to 130 or DBP greater than or equal to 80, and no hypertension
diagnosis. The individuals were given educational handouts about common signs and
symptoms and complications of uncontrolled HTN, lifestyle changes to improve BP, and
DASH diet recommendations (Owen, 2019).
Owen’s (2019) DNP project consisted of 635 eligible patients evaluated in both
pre-and post-intervention phases, including 301 in the pre-intervention and 334 in the
post-intervention stage. Average BP before the intervention was 121.1/76.3mmHg and
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122.3/78.6 post-intervention. The DNP project also found 30.2% or 91 out of 301
participants had undiagnosed hypertension before the intervention, and 35.9% or 120 out
of 334 had undiagnosed hypertension post-intervention. This increase in the postintervention group was the opposite of what was expected. Ultimately, both the ShapiroWilk test and the Wilcoxon rank-sum test were determined not to be valid. Although this
DNP project's findings were not what was expected and not statistically significant, the
data does indicate a large proportion of the population during the timeline of this project
had undiagnosed hypertension, suggesting a practice problem that should be addressed
(Owen, 2019).
Hypertension is a dangerous, common, costly, and fatal disease if left untreated.
In many incidences, hypertension can be treated and maintained with lifestyle
modifications such as dietary changes, weight loss, and exercise. Nagib (2019) conducted
a DNP quality improvement project, and the goal was to improve uncontrolled
hypertension through improving self-management strategies by creating educational tools
for hypertensive patients and follow-up face-to-face nursing visits for blood pressure
checks in the primary care setting. The timeline for this DNP project was eight weeks,
with data collected pre-intervention and post-intervention. The clinic staff was educated
on the proper way to take blood pressure. The participants were educated on utilizing an
automatic blood pressure cuff at home to record blood pressures. Criteria for inclusion
were individuals ages 20 to 85 years of age with uncontrolled hypertension. They
excluded underlying disease that causes uncontrolled hypertension such as hormonal
abnormalities, sleep apnea, renal artery stenosis, smoking, alcoholism, illicit drug use,
decongestants, corticosteroids, and nonsteroidal anti-inflammatory (NSAIDs)
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medications. A total of 12 patients were included in the DNP project. Blood Pressure
readings were collected pre-intervention, during a second nursing visit and a third nursing
visit, as well as post-intervention at two months after initial measurement (Nagib, 2019).
Nagib (2019) selected patient's interventions which included the DASH diet,
patient blood pressure logs, blood pressure recording table, reviewing blood pressure
techniques, and lifestyle changes to improve blood pressure. Utilizing the paired t-test,
blood pressure readings pre-intervention and post-intervention were measured. The
average pre-systolic BP was 152.17, and pre-diastolic BP was 89.09. The average second
SBP was 143.08, and the second DBP was 78.67, and the final average SBP was 129.67
and DBP 76.17. This DNP project's findings supported patient education through
educational handouts and having close follow-ups with patients to improve hypertension
values for hypertensive patients. However, this project's limitations are the small sample
size and should be conducted on a larger scale for a more robust statistical analysis
(Nagib, 2019).
Urgent care centers see a large numbers of patients each year for an array of
illnesses, injury, and primary care. Hypertension is one of the problems that is underdiagnosed, and the prevalence continues to increase, thus showing treatment should begin
being addressed in the urgent care setting. Treatment beginning earlier in patients can
help patients understand the risks associated with long-term uncontrolled hypertension
and improve outcomes. In addition, by providers having a better understanding of barriers
that patients experience can help improve medication adherence and help to reduce blood
pressures.
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Evidence-Based Practice: Verification of Chosen Option
Many individuals have uncontrolled or untreated hypertension and are unaware of
treatment and lifestyle changes that could be instituted for prevention and management.
This DNP project will provide better understanding of individual’s knowledge of
hypertension; in addition to providing educational materials to help these individuals
further maintain/manage their blood pressure.
After reviewing the literature findings suggested that patients have a lack of what
blood pressure measurements should be, what life-style modifications could be changed
to decrease and improve blood pressure, what long-term effects hypertension has on their
body, what barriers to care patients had, what providers needed to be educated on to
appropriately manage hypertension, and what providers could do to improve education
and compliance for patients. These findings implied there was a need for this DNP
project to help promote and improve hypertension education and management in the
urgent care setting.

Theoretical Framework/Evidence-Based Practice Model
Nola Pender’s Health Promotion Model is a middle-range integrative theory that
defines the goal of nursing care as optimal health (Butts & Rich, 2018). Pender’s
approach focuses on allowing improvement and treatment for the individual. The three
main categories of Pender’s Health Promotion Model are:
•

individual characteristics and experience,

•

behavior-specific cognitions and affect, and

•

behavioral outcomes (Butts & Rich, 2018).
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Every individual has unique personal characteristics and experiences that
subsequently affect their actions and view of health. Having an understanding of health
concerns, such as hypertension, facilitates patients being accountable for their health,
thereby, fostering improved outcomes. Healthcare providers can increase the well-being
of individuals by providing primary education and health promotion to manage
hypertension. Utilizing Pender’s Health Promotion Model will lead to behavioral change
in patients.
Questionnaires will follow the three main categories of Pender’s Health
Promotion Model. Questions for patients will be focused on individual understandings of
characteristics and experiences that can have an effect on blood pressure, behaviorspecific effects that can affect blood pressure and the behavioral outcome that will
improve blood pressure.
In addition to applying Pender’s Health Promotion Model, Imogene King’s
Theory of Goal Attainment will improve outcomes for individuals. The nine significant
concepts of goal attainment are:
•

communication,

•

growth and development,

•

interaction,

•

perception,

•

role,

•

space,

•

stress,

•

time, and lastly,
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•

transaction (King, 1981).

Healthcare providers who are interacting with individuals and communicating effective
health promotion behaviors will enable the transition to better health outcomes in
patients. Communication between healthcare provider and patients will increase the goal
attainment process and improve individual learning and coping mechanisms.
Imogene King’s Theory of Goal attainment will help guide this DNP project by
focusing on specific concepts of goal attainment. For this DNP project, communication,
perception, and time will be followed. Having effective communication of education
from providers to patients will increase the knowledge of blood pressure. In addition, the
communication will be enhanced by understanding the perceptions of patient’s
knowledge of blood pressure. Lastly, this theory will provide a timeline that could
improve patient’s blood pressure.
Goals, Objectives, and Expected Outcomes
The goal of this project was to first, improve the education of patients with
undiagnosed or uncontrolled hypertension by increasing patient education and disease
management to decrease blood pressure readings in the urgent care setting. Secondly, this
project was to provide education to providers about recommendations/guidelines and
education topics to discuss with patients. The following objectives were applied in order
to meet the project goals:
•

Provide education to patients who have blood pressure readings greater than or
equal to 130/80.

•

Start appropriate medication at the time of visit if warranted.

•

Check and analyze appropriate lab specimens.
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•

Follow-up with patients in appropriate timeframes.

•

The individuals will show a decrease in hypertension by the third month.

The expected outcome for this project was an increase in patients understanding,
knowledge, and management of hypertension over a three-month time span.

Project Design
This DNP project was structured using an educational teaching program with
evidence-based practice research and guidelines for both patients and providers in order
to reduce hypertension in patients. The DNP project manager provided teaching methods
to patients to understand hypertension management better and provider education about
specific topics that should be taught to patients, labs that should be followed, and followup periods for patients to improve both practice and process. The method that the writer
used was quantitative for patients’ blood pressure readings.
This project was a Pre- and Post-Test Design using quantitative data. Quantitative
data for this project was collected by measuring patients’ blood pressure at the initial
visit; then again at the three-month follow-up appointment. In addition, for this project a
pre- and post-questionnaire was given to patients. Patients completed the prequestionnaire prior to any intervention to access knowledge level. The post-questionnaire
was given post-educational intervention to access knowledge gained.
By implementing this project, the project leader hoped to demonstrate a process
improvement to providers by showing exactly what can help patients with hypertension
and a practice intervention by specifically showing improvement in both patient
education and blood pressures.
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Project Site and Population
The project took place in an urban urgent care setting, with medium household
income of $143,221, that manages both acute illnesses and primary care (DataUSA,
2020). The urgent care facility sees patients with acute diseases and injuries such as
upper respiratory infections, sinusitis, urinary tract infections, fractures, etc., in addition
to chronic conditions such as hypertension, diabetes, and so forth. The urgent care
providers had patients from infancy to geriatric age for any condition as previously
mentioned and more. The participants for this project were men and women greater than
or equal to 18 years of age and older, as well as the providers (nurse practitioners,
physician’s assistants, and physicians). Recruitment of participants was from patients
coming in for office visits. Inclusion criteria was patients:
•

With a SBP greater than or equal to 130 or DBP greater than or equal to 80.

•

Age of 18 or older.

•

Having no primary care provider.

•

Having had no previous management of blood pressure.

Exclusion criteria was patients:
•

Less than 18 years old age.

•

Already on hypertension management.

•

Having a primary care provider.

Setting facilitators.
The resources that were available for this project were patients coming in for
visits and being able to diagnosis hypertension at these visits. This process was facilitated

26

by providing a questionnaire for ancillary staff to ask patients to find out information
such as primary care providers or diagnosis of hypertension.
Setting barriers.
Constraints and barriers existing with this project were patients believing to have
normal blood pressure usually and believing blood pressure was elevated due to illness or
injury going on at the time of the urgent care visit. Additionally, a barrier that existed for
this DNP project was failure of patients to follow-up with scheduled appointments or to
show up when the project manager was not on site. To overcome the barrier of the
patient believing they have normal blood pressure usually, the blood pressure will be
checked twice 15 minutes apart. Depending on the actual blood pressure readings the
patient was directed to self-check blood pressure at home and follow-up at a given time.
If patients failed to follow-up at the given time frame, the project leader provided a
telehealth visit with the patient. Additionally, constraints to patient follow-ups were due
to the setting being in urgent care and implementation taking place during the COVID-19
pandemic. Lastly, a constraint was the socioeconomical status of the community.

Implementation Plan/Procedures
Implementation of this project will include a two-pronged approach. There will be
provider education and patient education.
Provider Education
A provider questionnaire was given to all physicians, nurse practitioners, and
physician assistants in order to assess provider knowledge of hypertension management
and understanding. This questionnaire included the following:
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•

What are the current recommendations for hypertension?

•

What education topics should be discussed with patients?

•

What labs specimens should be collected for hypertension?

•

What is the appropriate timeframe for follow-up for patients with
hypertension?

This portion of the project was not completed due to permission not being granted
for use of survey. An educational intervention (Appendix A) was conducted for providers
via email.
Patient Education
To implement the management of hypertension in patients; the starting point began
with the triage of patients. Each patient had their blood pressures taken to determine
eligibility to participate in the project. If the blood pressure met criteria, the patient was
asked if they have a diagnosis of hypertension or have a primary care provider. If a
patient was eligible to participate, the researcher explained the DNP project to the patient,
asked them to participate, and initiated informed consent. When collecting data, patients
answered a questionnaire about their understanding of hypertension (Appendix B)
(hypertension, ways hypertension can be controlled, and the long-term effects of
uncontrolled hypertension). Next, the project manager provided a hypertension
educational intervention (Appendix C), had the patient complete a post-questionnaire,
and scheduled the patient follow-up appointments at three months. A post-questionnaire
was completed immediately following the educational intervention and again at the threemonth follow-up to assess the knowledge gained and retained. Blood pressure readings
were conducted on the initial visit and again at a three-month follow-up to assess for
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improvement based upon the educational intervention. Depending on severity of
hypertension, follow-up could have been sooner than three months.
Measurement Instruments
To measure the outcomes of this DNP project, the following instruments were
used for collection and follow-on blood pressure: sphygmomanometer. Blood pressure
readings were obtained on the initial visit and again at the three-month follow-up visit.
For this project, the pair t-test was utilized, which tested the difference between two of
the same groups at different points (Sylvia & Terhaar, 2014). A pre-questionnaire for
patients was conducted and then was performed again after education had been provided.
The post-intervention questionnaire for providers was conducted after education had been
completed. The post-intervention survey for patients was at three-months.
Data Collection Procedure
To implement this DNP project, the writer assessed individuals who presented to
the urgent care setting. The project leader checked all blood pressures in the electronic
medical record (EMR) after the medical assistant had triaged patient. Any individual who
had a SBP greater than or equal to 130 or DBP greater than or equal to 80 and had no
current medication for blood pressure, the project leader went in and spoke with the
individual. The project leader began by introducing themselves and confirmed the
individual was not taking any medication for hypertension, ensured the individual had no
diagnosis of hypertension, and no primary care provider. If the individual answered yes
to any of the above, the individual was excluded. Next, the project leader explained the
objectives, goals, risks, and benefits of the project. The individual then was asked if
he/she would like to participate. If individual wanted to not participate, the project leader
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would exit the room, if individual wanted to participate the project leader would have
patient sign informed consent, and consent to participate in research. The project leader
would then have the individual complete a pre-questionnaire and then provide education
about hypertension goals, effects, treatments, and follow-up recommendations. After
education had been provided, the individual completed a post-questionnaire. The project
leader then provided individuals with education materials to take home and a follow-up
date for blood pressure recheck and questionnaire.
To evaluate the effectiveness of this DNP project, analysis of blood pressure, prequestionnaire, and post-questionnaire, which occurred three-months after the initial visit
(unless follow-up was sooner based off blood pressure). The project leader then
statistically analyzed data to learn what baseline knowledge individuals had about blood
pressure, if knowledge increased after education was provided, if education was retained
at three- months, and if blood pressure had a decrease with lifestyle modifications the
individuals made after education materials were taught and provided.
Project Recruitment
For the recruitment of this project, patients presented to this urgent care clinic
with an acute illness or injury. After the initial triage of patients took place, anyone with
an elevated blood pressure and no diagnosis of hypertension was consulted with
regarding DNP project participation. If the patient agreed to participate in the DNP
quality improvement project, informed consent was obtained prior to any collection of
data.
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Intervention Steps
Patients. Once the patient had agreed to participate in the DNP project and signed
consent to participate, the DNP project leader provided educational intervention on
hypertension with the patient. This process included asking the patient to complete a preintervention questionnaire. After the patient had completed the pre-questionnaire, the
DNP project leader provided educational intervention for the patient on what causes
hypertension, the long-term effects of hypertension, and ways hypertension can be
managed. The patient then completed the post-questionnaire. The DNP project leader
decided if medication was warranted at the current blood pressure reading or if lifestyle
modifications could be trialed. The provider then ordered appropriate labs. The patient
was then scheduled for a follow-up visit at three-months to assess knowledge retention
and collect blood pressure readings.
Providers. Providers were to be given a pre-questionnaire, and then the DNP
project leader was to provide an educational intervention. Education for providers was on
the specific provider-patient education that should be completed with patients during the
clinic visit, appropriate labs that should be ordered, appropriate medication choices, and
an appropriate follow-up time period. The plan was to have providers complete a postquestionnaire to determine if there was an increase in educational knowledge. However,
the DNP project manager was not able to carry out this portion of the plan because access
to the questionnaire was not granted. The provider questionnaire was not completed and
only provider education was accomplished.
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Data Analysis
Analysis of this DNP project utilized a paired t-test, which compared the same
group of patients at different periods. The goal of this evaluation was to see if there was
an improvement in the management of hypertension and knowledge of understanding of
the cause of hypertension after an initial visit and three-month follow-up. Patient
education was measured based on pre- and post-questionnaire findings. Management of
blood pressure was measured by blood pressure readings at the initial visit and at the
three-month follow-up visit.
The DNP project leader utilized a statistician to perform the data analysis. Data
was entered into an excel spreadsheet with each patients’ pre, post, and three month
scores, along with the initial and three-month follow-up blood pressures. Data was then
imported from the excel spreadsheet into SPSS to determine statistical significance. A
paired-t test was utilized to perform an analysis of pre- and post-questionnaire results,
post and three-month questionnaire results, and systolic and diastolic blood pressure from
initial visits to three-month visits. To determine if data had statistical significance the pvalue was set less than or equal to .05.
Results
This DNP project was completed with a sample size of 25 patients. The age range
of participants ranged from 18 to 70 years old, both male and female. The sample
consisted of 15 males and 10 females. None of the participants had a primary care
provider or a past medical history of hypertension. The participant outcomes were
measured by the pre, post, and three-month post hypertension knowledge test.
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Additionally, the participants systolic and diastolic blood pressure at the initial visit and
the three-month follow-up were compared.
The median score for participant’s knowledge pre-test was 70% and post-test was
90%. To determine if the DNP project data collected from the pre, post, and three-month
post-test were statistically significant a paired t-test was conducted. The p-value for the
pre- and post-test comparison was less than .001, which is less than .05 (Figure 1);
therefore, the results determined there was a statistically significant difference between
pre and post scores. The patients on average scored better following education and their
scores were higher by 0.212 points (21.2%).

Figure 1

The results for patients’ post-test and three-months post-test also demonstrated
statistical significance. The post-test results were 90% and the three-month results were
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100%. The p-value for this data was less than .001 which is less than .05, thus confirming
statistical significance (Figure 2).

Figure 2

The systolic and diastolic blood pressure median was higher than the median
blood pressure at the three-month post-visit. The mean systolic blood pressure initially
was 145 and at follow up was 137. The mean decrease of systolic blood pressure was
eight. The p-values for this was a difference of less than .001; therefore, validating
statistical significance (Figure 3). The mean diastolic blood pressure initially was 91 and
at follow up was 88. The mean decrease in diastolic blood pressure was 4. The p-value
was 0.039, which determined statistical significance (Figure 4).
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Figure 3

Figure 4
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Interpretation/Discussion
This DNP Project intervention, which combined patient education and a pre- and
post-questionnaire utilizing constructs from the Health Promotion Model and Imogene
King’s Theory of Goal Attainment, were effective in improving patient knowledge level
regarding high blood pressure as well as decreasing systolic and diastolic blood pressure
short-term. These findings suggest this intervention would be effective for patients with
no primary care provider who are lacking in education regarding high blood pressure or
are unaware of having high blood pressure. This type of intervention could be utilized in
other chronic conditions in the urgent care setting. In addition, this type of intervention
could be utilized in the primary care setting for newly diagnosed patients with chronic
conditions.
Limitations
This DNP project does have limitations due to the location and educational level
of patients in the location where the study was completed. In addition, since this project
was completed in a walk-in urgent care setting, patients were unable to schedule followup appointments and had to be notified by phone call to return to the clinic for follow-up.

Cost-Benefit Analysis/Budget
For this DNP project, the project leader needed a sphygmomanometer for blood
pressure readings and access to paper and printer services for educational materials for
both patients and providers. The cost of this was provided by the facility, which did not
increase cost due to patients receiving educational handouts already. In addition, the
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project leader had provided and printed questionnaires for data collection about patients
pre- and post-educational sessions. The actual costs of supplies are as follows:
•

Sphygmomanometer $22.98

•

Stethoscope $99.98

•

Printer Paper $3.97 per pack

•

Printer $349.99

•

Toner $76.99

Timeline
The timeline (Appendix D) for this DNP project began with Institutional Review
Board (IRB) (Appendix E) and Project Evaluation and Review Committee (PERC)
committee approval in October. Subject recruitment began in October once IRB approval
had been obtained. Data collection began in October with the initial visit and continued at
the three-month follow-up appointment. Data analysis began in April 2021 with the
interpretation of results following.

Ethical Considerations/Protection of Human Subjects
The Jacksonville State University IRB approval (Appendix E) was obtained
before initiating the DNP project. The project leader participated and completed the
Jacksonville State University IRB and CITI (Appendix F) training courses. All
participants were protected by the Health Insurance Portability and Accountability Act of
1996 (HIPAA) which, among other guarantees, protects the privacy of patients’ health
information (USDHHS, 2020). Prior to participation in this DNP project, the project
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leader obtained informed consent (Appendix G) and participation in research (Appendix
H) from the participant. The list of patients and providers who participated in this project
was kept within a locked cabinet, only accessible by the project leader. Participant
confidentiality was assured by coding participants with an individual unique
identification number. Any electronic files containing identification or protected health
information was password protected to prevent unauthorized access. The risks to patients
participating in this project were no different from the risks of patients receiving standard
care in the urgent care setting.

Conclusion
In conclusion, urgent care centers see a vast number of individuals annually,
many of which do not have primary care providers and have undiagnosed hypertension.
A diagnosis of hypertension is when a systolic blood pressure greater than or equal to 130
or a diastolic blood pressure greater than or equal to 80. Hypertension if left untreated can
lead to heart attack, stroke, kidney failure, and multiple other problems. Literature shows
that many individuals do not know the normal range for blood pressure or the longlasting effects of untreated hypertension. In addition, many individuals are not sure what
can be done to decrease blood pressure prior to medication being started. The patient’s
knowledge level regarding hypertension should be assessed, proper education should be
provided, and educational material should be given. This DNP project revealed
statistically significant data in that individual’s knowledge about hypertension increased
after educational materials were given, knowledge was retained over a three-month
period, and that both systolic and diastolic blood pressure decreased. This study proved
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that urgent care centers should focus on providing more educational materials for patients
as well as scheduling additional primary care visits for patients to adequately treat blood
pressure sooner rather than later.

Implications for Nursing
This DNP project demonstrated there was an increase in individuals’ educational
knowledge and improvement in blood pressure. This proves the need for future DNP
projects focused on hypertension education. In addition, this project could be carried out
on a larger scale to show educational knowledge and blood pressures readings over a sixmonth period and one-year period.
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Hypertension
Guideline Toolkit
Nearly half of American adults have high blood
pressure, but you can make a difference.
The 2017 Guideline for the Prevention, Detection, Evaluation and
Management of High Blood Pressure in Adults (2017 Hypertension
Clinical Practice Guideline) has important implications for the treatment

of nearly 103 million adults in the United States. As healthcare providers,
you need resources to help you integrate the new guideline into
your practice so you can
provide optimal care
for patients
with elevated
blood pressure (BP)
or hypertension.

American Heart Association’s efforts to improve healthy choices
related to living with high blood pressure is proudly supported by TYLENOL®.

heart.org/bptools

HIGHLIGHTS

CONTENTS
This toolkit offers
you a variety
of essential
guideline-related
resources:
3 HBP is associated
with these lifethreatening
diseases
4 CVD risk factors
tied to hypertension
5 Definitions
of normal and
elevated BP and
hypertension
7 Diagnosing BP
9 Meds that can
contribute to high
blood pressure

PLUS
• Summaries of
evidence-based
recommendations
• Links to treatment
algorithms
• Printable resources
to help your patients

In Practice
Top 10 Things to Know

2

5 Things to Know
From the 2017 Hypertension Guideline
that Will Impact Your Clinical Practice
From the 2017 Hypertension Clinical Practice Guideline

1

Blood pressure classifications have changed.
The guideline establishes a new evidence-based classification of BP in adults, with hypertension defined by systolic and
diastolic BPs that are lower than the previous thresholds.

2

The prevalence of hypertension in America is
higher. Nearly half of all adults in the United States will
have high BP under the updated classifications.

3

Treating high blood pressure begins with
accurate measurements. Accurate measurement
of BP is essential for categorizing BP, determining the risk of
atherosclerotic cardiovascular disease and managing high
BP. Diagnosis and management of hypertension should be
based on accurate measurements not only in the office but also
through self-monitoring.

4

Lifestyle changes are a first line of treatment for
many patients. Nonpharmacologic interventions aimed
at addressing poor dietary habits, physical inactivity, and/or
excessive consumption of alcohol are fundamentally important
in managing the underlying causes of high BP in most adults.
Healthcare providers should also discuss the importance of
medication management and discuss all prescription and overthe-counter medications with patients.

5

Team-based approach to improving treatment
and control in adults with high blood pressure.
Most adults receiving antihypertensive drug therapy have an
average systolic BP and/or diastolic BP above the target level
recommended in this guideline. Recommendations to improve
treatment and control are provided, including a team-based
approach to management.
Hypertension Guideline Toolkit for Healthcare Providers

THE PROBLEM

The Domino Effect
High blood pressure is often
the first domino in a chain
or “domino effect” leading to
devastating consequences, like:

Coronary heart disease
Higher BP has been associated with
an increased risk of CVD, and the rate
of myocardial infarction increases as
BP increases.
Stroke
Hypertension is the leading modifiable risk
factor for stroke, with hypertension causing
approximately half of all strokes.

STROKE

VISION LOSS

HEART FAILURE
HEART ATTACK

Heart failure
High BP is associated with increased risk
of heart failure in both men and women,
and as many as 91% of patients with newly
diagnosed heart failure have a history of
hypertension.
Kidney disease/failure
Hypertension is the second leading cause
of kidney failure, and nearly half of patients
with chronic kidney disease do not have
adequately controlled hypertension.

KIDNEY FAILURE

.

SEXUAL
DYSFUNCTION

Vision loss
Long-term hypertension can harm vision
in many ways, including retinopathy,
choroidopathy (fluid buildup under the retina)
and optic neuropathy.

In Practice
Hypertension, the “silent
killer,” is associated with
a variety of life-threatening
diseases or conditions.

Help your patients to avoid the
serious problems that can result
from blood pressure being too high
for too long.
3

THE RISK

Hypertension and CVD Risk Factors
The guideline recommends screening for and managing these risk factors.
Several modifiable CVD risk factors are commonly found
in people with hypertension, including:
Current cigarette smoking, secondhand smoke

In addition, several
relatively fixed risk
factors associated with
hypertension should be
considered, including:
• Chronic kidney disease

Diabetes mellitus

• Family history

Dyslipidemia/hypercholesterolemia

• Increased age

Overweight/obesity

• Low socioeconomic/
educational status

Physical inactivity/low fitness

• Male sex
• Obstructive sleep apnea

Unhealthy diet

• Psychosocial stress

In Practice
Help your patients

Nearly half of American adults have
high blood pressure.

understand the risks
of high BP and the
substantial benefits
of lowering their BP.
Emphasize the central
role they play in
preventing and
managing elevated BP.

A 10 mm Hg reduction in systolic blood pressure can significantly
reduce risk of several conditions:
Coronary
Heart Disease

4

17%
reduced
risk

Stroke

27%
reduced
risk

Heart
Failure

28%
reduced
risk

Hypertension Guideline Toolkit for Healthcare Providers

RISK FACTORS/NEW CATEGORIES

NEW

Categories of Hypertension

The new categories
reflect a more aggressive
approach to managing
BP, with elimination
of the prehypertension
category, and lowering
of the threshold
for hypertension to
130/80 mm Hg.

BP CATEGORY

BP (MM HG)
Systolic

Diastolic

NORMAL

<120

and

<80

ELEVATED

120-129

and

<80

HYPERTENSION
Stage 1

130-139

or

80-89

Stage 2

≥140

or

≥90

>180

and/ >120
or

HYPERTENSIVE
CRISIS

In Practice
Help your patients understand their BP readings.
Print this table, circle their BP category, and give
it to them along with other appropriate resources.
The table is available in English, Spanish and
Traditional Chinese.
5

PREVALENCE

Prevalence of Hypertension
According to the new BP threshold, hypertension
(≥130/80 mm Hg) affects approximately
46% of the U.S. adult population.
The prevalence varies according to sex, age and race-ethnicity, with the highest
prevalence found among people 75 years or older, especially women, and in the
non-Hispanic black population.

Patient Characteristics

BP≥130/80 mm Hga
Men (n=4717)

Overall Crude
Age-sex adjusted

Women (n=4906)
46%

48%

43%

20-44

30%

19%

45-54

50%

44%

55-64

70%

63%

65-74

77%

75%

79%

85%

Non-Hispanic white

47%

41%

Non-Hispanic black

59%

56%

Non-Hispanic Asian

45%

36%

Hispanic

44%

42%

Age group (yr)

≥75
Race-ethnicity

b

Or self-reported use of antihypertensive medication.
Adjusted to the 2010 age-sex distribution of the U.S. adult population.

a
b

Prevalence of Hypertension Based on 2 SBP/DBP Thresholds
Download PDF of table with full detail

6
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DIAGNOSING

Diagnosing BP
The appropriate diagnosis of elevated BP
or hypertension should involve accurate
measurement of BP, self-monitoring of BP in the
home, screening for white-coat hypertension
or masked hypertension and for secondary
causes of hypertension, and evaluating
the use of BP-increasing medications and
substances. In addition, BP readings from selfmonitoring should be integrated into practice
to confirm the diagnosis. For patients with a
diagnosis of stage 1 hypertension, the ASCVD
Risk Calculator should be used to estimate
the patient’s 10-year and lifetime risk for
atherosclerotic CVD. This estimate is a factor
in determining the most appropriate treatment.
A team-based approach is recommended.

In Practice
Download the ASCVD Risk
Calculator or launch a web version.

can have the greatest impact on improving the
monitoring and management of blood pressure.
The guideline describes six key steps
for proper measurement of BP.

STEPS FOR ACCURATE BP MEASUREMENT
1
SEAT PATIENT WITH FEET FLAT ON THE
FLOOR, RELAXED AND QUIET FOR 5 MIN.
HAVE PATIENT EMPTY BLADDER AND AVOID
CAFFEINE, EXERCISE AND SMOKING FOR
30 MINUTES. REMOVE CLOTHING FROM ARM.

3

2

FIRST VISIT, RECORD BP IN BOTH
ARMS, USING THE ARM WITH
HIGHER READING. SEPARATE
REPEATED MEASUREMENTS
BY 1-2 MINUTES.*

USE PROPERLY VALIDATED,
CALIBRATED BP MEASUREMENT
DEVICE. SUPPORT PATIENT’S ARM
AND POSITION CUFF ON BARE ARM
AT LEVEL OF THE RIGHT ATRIUM.
USE CORRECT CUFF SIZE.
Usual sizes based on arm circumference:
22-26 cm = Small Adult
27-24 cm = Adult
35-44 cm = Large Adult
45-52 cm = Adult Thigh

*For auscultatory determinations, use a palpated estimate of
radial pulse obliteration pressure to estimate SBP. Inflate the cuff
20-30 mm Hg above this level for an auscultatory determination
of BP level. For auscultatory readings, deflate the cuff pressure,
2 mm Hg per second and listen for Korotkoff sounds.
**For auscultatory technique, record SBP and DBP as onset of
the first Korotkoff sound and disappearance of all Korotkoff
sounds respectively, using the nearest even number.

4

5

6

RECORD SBP AND DBP**. NOTE
TIME OF MOST RECENT BP MED
TAKEN BEFORE MEASUREMENT.

USE AN AVERAGE OF 2 READINGS
OBTAINED ON 2 OCCASIONS TO ESTIMATE
THE INDIVIDUAL’S LEVEL OF BP.

PROVIDE PATIENT THE
SBP/DBP READINGS BOTH
VERBALLY AND IN WRITING.

AHA recommended blood pressure levels
LEARN MORE AT
HEART.ORG/HBPROUTINE

American Heart Association’s efforts to improve
healthy choices related to living with high blood
pressure is proudly supported by TYLENOL®.

BLOOD PRESSURE CATEGORY

SYSTOLIC mm Hg
(upper number)

DIASTOLIC mm Hg
(lower number)

NORMAL

LESS THAN 120

and

LESS THAN 80

ELEVATED

120-129

and

LESS THAN 80

130-139

or

80-89

140 OR HIGHER

or

90 OR HIGHER

HIGH BLOOD PRESSURE
(HYPERTENSION) STAGE 1
HIGH BLOOD PRESSURE
(HYPERTENSION) STAGE 2
HYPERTENSIVE CRISIS

HIGHER THAN 180

and/or HIGHER THAN 120

© 2018 American Heart Association, Inc., All rights reserved.

Measuring BP
Accurate measurement of BP is essential
to proper prevention, detection and
management of BP. Errors in measuring
BP can have a substantial effect on BP,
with estimated changes of 2 to 50 mm Hg.
Recognizing the importance of accurate
measurement of BP, the 2017 guideline
focuses on the standards for accurate
measurement of BP.
A team-based approach to care is recommended.
Such an approach has been associated with
lower systolic and diastolic measurements as
well as an increased proportion of people with
controlled BP. Teams consisting of physicians,
nurses, physician assistants and pharmacists

Use of the wrong size cuff is the most common
error in measuring BP. The discrepancy in
systolic BP can be as great as 10 mm Hg if
the cuff is too small; the difference in diastolic
BP can be as great as 8 mm Hg. To ensure
accurate measurements, the guideline offers
the following recommendations for selecting
the appropriate size cuff.
Arm Circumference
(cm, inches)

Usual Cuff
Size

22-26 (8.5-10.2)

Small adult

27-34 (10.6-13.3)

Adult

35-44 (13.8-17.3)

Large adult

45-52 (17.7-20.5)

Adult thigh
7

DIAGNOSING

Screening for White-Coat
and Masked Hypertension
The prevalence of white-coat or masked
hypertension has been approximately 10%
in population-based surveys and in as many
as 33% of patient registries. These conditions
can have a substantial impact, with white-coat
hypertension leading to overtreatment and
masked hypertension to undertreatment.
An important component of accurately
diagnosing elevated BP or hypertension is
screening for these two phenomenon.
The guideline states it is reasonable to screen
for white-coat hypertension in adults with:
• untreated systolic BP
>130 mm Hg, < 160 mm Hg
• diastolic BP:
> 80 mm Hg, < 100 mm Hg
It is reasonable to screen for masked
hypertension for adults with untreated
office-measured BPs that are consistently
120-129 mm Hg (systolic) or
75-79 mm Hg (diastolic)

•
•
•
•

Obstructive sleep apnea (25-50%)
Renovascular disease (5-34%)
Primary aldosteronism (8-20%)
Drugs or alcohol such as sodium containing
antacids, caffeine, nicotine, NSAIDS, oral
contraceptives and others (2-4%)
• Renal parenchymal disease (1-2%)
Note: Some uncommon, but important
causes of secondary hypertension include
pheochromocytoma/paraganglioma,
Cushing’s syndrome, hypo- or hyperthyroidism,
aortic coarctation and others.

Algorithms for Detecting White-Coat
or Masked Hypertension

See more information on secondary
hypertension, clinical implications, prevalence,
physical examination and screening tests.

• Patients Not Receiving Drug Therapy
• Patients Receiving Drug Therapy

Algorithm for Screening for Secondary
Hypertension

Self-Monitoring of BP
Patient self-monitoring of BP is an
important focus of the 2017 guideline.
Patient training should be done under
medical supervision, with focus on
evaluating the device used in the home
and providing detailed instructions
for proper measurement.
8

Screening for Secondary Hypertension
Determining whether hypertension has a
secondary cause is also a component of
the appropriate diagnosis of elevated BP
or hypertension. Secondary causes of
hypertension are responsible for high BP
in approximately 10% of patients with
hypertension. The following are the most
common causes of secondary hypertension
with prevalence indicated in parentheses.

In Practice
Emphasize the importance of
monitoring BP at home and
encourage patients to use online
resources to help ensure accurate
measurements and tracking.
Hypertension Guideline Toolkit for Healthcare Providers

IDENTIFYING BP RAISERS

Identifying Medications and Substances
that May Cause Elevated BP
Several medications and other substances
may cause an elevated BP. Be sure to ask
your patients about their use of medications,
including over-the-counter medicines or other
substances. Discuss how these substances may
increase BP and identify any that your
patients should avoid, limit or stop to
help maintain a healthy BP.
Chronic pain affects more adults than coronary
heart disease, diabetes and cancer combined. As a result, the use of pain relievers is
common. Nonsteroidal anti-inflammatory drugs
(NSAIDs) can increase BP because they reduce
renal blood flow and cause sodium retention.
Patients older than 65 years are at most risk
for this effect. For patients with high blood
pressure, pay extra attention when selecting
medications for pain relief. Certain pain
relievers can interfere with their hypertension
management.

BP Raisers
Learn What Could Raise Your Blood Pressure

Many things can affect your blood pressure (BP). It is critical to understand what medications
and substances you should avoid to support a healthy BP.
SMALL CHANGES CAN MAKE A BIG DIFFERENCE
Be your own health advocate by following a healthy lifestyle, such as reducing sodium
and checking your blood pressure as part of your daily routine.
High blood pressure – a systolic blood pressure reading of 130 mmHg and above or a diastolic
reading of 80 mmHg and above – is a serious health condition that can increase your risk of
heart disease and stroke. Take these steps to control your risk.

AVOID:
• Herbal supplements

TALK TO YOUR HEALTHCARE
PROVIDER ABOUT STARTING,
STOPPING OR CHANGING:

• Foods that contain tyramine when
taking antidepressants, such as MAOIs
(monoamine-oxidase inhibitors)

• Amphetamines

• Illicit and recreational drugs

• NSAID pain medication (drugs like
acetaminophen are less likely to increase BP)
• Certain medications to treat mental health
• Corticosteroids, such as prednisone

LIMIT:
• Alcohol to less than 1 drink a
day for women and less than
2 drinks a day for men
• Caffeine to less than 300 mg per day
(about 2-3 cups of coffee); avoid with
hypertension
• Decongestants and some cold
medicines; avoid with severe or
uncontrolled hypertension

• Immunosuppressants
• Oral birth control (consider alternative
forms such as barrier, IUD, abstinence)
• Certain cancer medications
(such as angiogenesis inhibitors)
NOTE: Do you suffer from chronic pain? Certain
medicines can raise your BP or make your BP
medication less effective. Talk to your healthcare
provider for guidance if you have any questions.

American Heart Association’s efforts to improve healthy choices related
to living with high blood pressure is proudly supported by TYLENOL®.

heart.org/bptools
© 2018 American Heart Association, Inc., All rights reserved.

Download this infographic to help
easily identify potential BP Raisers.

In Practice
Encourage your patients to talk openly
about what over-the-counter medicines
and substances they consider using.
Print the list of medications and
substances shown above, create an

encouraging environment and start
the conversation with your patients.
Encourage patients with elevated BP
or hypertension to consider using pain
relievers other than NSAIDs.
9

TREATMENT – NONPHARMACOLOGIC

Treating Elevated BP
or Hypertension
Guideline-recommended treatment includes
nonpharmacologic interventions for patients
with elevated BP or stage 1 hypertension
and an estimated 10-year CVD risk of less
than 10%.
A combination of antihypertensive medication
and nonpharmacologic interventions is
recommended for patients with stage 1
hypertension and an estimated 10-year
ASCVD risk of 10% or higher and for all
patients with stage 2 hypertension.

In Practice
Talk to your patients about the
benefits of lifestyle changes in
reducing BP. Give them the “What
Can I Do To Improve My Blood
Pressure” resource as a reminder

for them at home.

10

Nonpharmacologic Interventions
The guideline recommends several
nonpharmacologic interventions that
have been shown to reduce systolic BP by as
much as 11 mm Hg in adults with hypertension.
These interventions also can help prevent
hypertension in adults with normal BP.

•
•
•
•
•
•

Weight loss for patients who are
overweight or obese
Heart-healthy diet (such as DASH)
Sodium restriction
Potassium supplementation (preferably in
dietary modification)
Increased physical activity with structured
exercise program
Limitation of alcohol to 1 (women) or
2 (men) standard drinks per day

Hypertension Guideline Toolkit for Healthcare Providers

TREATMENT – PHARMACOLOGIC

Antihypertensive Medication
The BP threshold for antihypertensive
medication should be determined on the
basis of the average BP levels and CVD risk.
BP Threshold
(mm Hg)

Patient
Scenario

≥130/80

ASCVD risk
of 10% or higher
OR
Clinical CVD

≥140/90

ASCVD risk
less than 10%

Six general classes of oral antihypertensive
drugs are recommended as second-line agents.
• Diuretics (loop, potassium sparing and
aldosterone antagonists)
• Beta-blockers (cardioselective,
and vasodilatory, noncardioselective,
intrinsic sympathomimetric activity
and combined alpha- and beta-receptor)
• Direct renin inhibitor
• Alpha-1 blockers
• Central alpha2-agonist and other
centrally acting drugs
• Direct vasodilators
Oral Antihypertensive Drugs

Four classes of oral antihypertensive drugs
are recommended as first-line agents for the
treatment of hypertension.
• Thiazide or thiazide-type diuretics
• Angiotensin-converting enzyme (ACE)
inhibitors
• Angiotensin receptor blockers (ARBs)
• Calcium-channel blockers (dihydropyridines
and nondihydropyridines)

Simultaneous use of an ACE inhibitor, ARB
and/or renin inhibitor is potentially harmful
and is not recommended for the treatment of
adults with hypertension.

Follow-up
Follow-up visits to reassess BP and monitor adherence and response to treatment should be
regularly scheduled according to guideline recommendations. Use of self-monitoring, team-based
care and telehealth strategies is recommended.

BP Status

Recommended Follow-up/Reassessment

Normal

1 year

Elevated

3-6 months

Stage 1 hypertension

Monthly until BP goal met with BP lowering medication
+ nonpharmacologic interventions
3-6 months after BP goal met

Stage 2 hypertension

Monthly until BP goal met with BP lowering medication
+ nonpharmacologic interventions
3-6 months after BP goal met
11

TREATMENT

Treatment
of Hypertension
in Patients With
Comorbidities
When setting BP thresholds and
goals of pharmacologic therapy,
you should consider your patients’
comorbidities.

For the following comorbidities:
• Diabetes mellitus
• Chronic kidney disease
• After renal transplantation
• Heart failure
• Stable ischemic heart disease
• Peripheral artery disease

BP Threshold ≥130/80 mm Hg
BP Goal <130/80 mm Hg
For secondary stroke prevention

BP Threshold ≥140/90 mm Hg
BP Goal <140/90 mm Hg

The guideline also includes several recommendations for specific antihypertensive medications
according to these comorbidities as well as others, such as acute intracerebral hemorrhage,
atrial fibrillation, valvular heart disease and aortic disease.

Resistant Hypertension
In clinical trials, resistant hypertension has developed in approximately 20% to 35% of patients
with hypertension. It is important to address resistant hypertension because of an associated
increased risk of cardiovascular events. The guideline defines treatment resistance and offers
recommendations for evaluating and treating patients.
Algorithm for Diagnosis, Evaluation and Treatment

12
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SPECIAL PATIENT GROUPS AND EMERGENCIES

The guideline recommends special
attention to specific patient groups.
Recommendations include:
Black adultsa
Initial antihypertensive treatment should
include a thiazide-type diuretic or a calciumchannel blocker. Two or more antihypertensive
medications are especially recommended
to achieve a BP target of less than
130/80 mm Hg.
Pregnant women
Antihypertensive medication should be
transitioned to methyldopa, nifedipine and/
or labetalol during pregnancy. ACE inhibitors,
ARBs or direct renin inhibitors should not be
used during pregnancy.
Persons 65 years and olderb
For patients with an average systolic BP of
130 mm Hg or higher, the treatment goal
should be a systolic BP of less than
130 mm Hg.
For patients with hypertension and a high
burden of comorbidity and limited life
expectancy, clinical judgment, patient
preferences and a team-based approach
should be used to assess risk/benefit for
decisions regarding intensity of BP lowering
and choice of antihypertensive medications.

Hypertensive Crises:
Emergencies and
Urgencies
Hypertensive
emergencies

BLOOD
PRESSURE
HIGHER THAN
180/120 mm Hg
IS A CRISIS.

are defined as
severe elevation
of BP (greater than 180/120 mm Hg)
associated with evidence of new or
worsening target organ damage.
In such cases, BP must be immediately
reduced to prevent or limit further
damage.
Hypertensive urgencies are defined as
severe elevation of BP (greater than
180/120 mm Hg) in otherwise stable
patients without acute or impending
change in target organ damage or
dysfunction.
The guideline provides an algorithm
for diagnosing and managing a
hypertensive crisis, as well as a list
of intravenous antihypertensive drugs
for treating hypertensive emergencies.
Intravenous Antihypertensive Drugs
for Treatment of Hypertensive
Emergencies

Read the full guidelines for
instructions on persons undergoing
surgical procedures.
Includes adults with diabetes mellitus but not heart failure or chronic kidney disease.
Noninstitutionalized ambulatory community-dwelling persons.

a
b
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SMALL CHANGES MAKE A BIG DIFFERENCE

Strategies to Improve
Control of Hypertension
In addition to a team-based approach to managing hypertension,
other strategies focus on promoting lifestyle modifications and
improving adherence to antihypertensive medication.
Promoting lifestyle modifications
Small changes can make a big difference.
Patients adopting and maintaining lifestyle
modifications can improve their blood
pressure. Encourage the use of strategies
that can help promote necessary behavioral
changes, such as the following:
• Set goals
• Provide feedback
• Emphasize importance
of self-monitoring
• Promote self-sufficiency
• Schedule consistent follow-up
• Use motivation interventions

These strategies are
most effective when
combined.

14
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MEDICATION ADHERENCE

Only 20%

of patients have sufficiently high adherence
to antihypertensive therapy to achieve
the benefits found in clinical trials.

In Practice

Improving adherence to
antihypertensive medication
Adherence to antihypertensive therapy is
suboptimal, with only 20% of patients having
sufficiently high adherence to achieve the benefits
found in clinical trials. Use strategies that
have been found to be effective in
improving adherence, such as the
following:
• Educate patients about hypertension,
its consequences and potential side effects
of medication
• Collaborate with patients to establish
goals of therapy and plan of care
• Prescribe medication as once-daily dosing
• Integrate pill-taking into routine activities
of daily living with support tools such
as reminders, pillboxes, packaging and
other aids

Consider the cultural and social
contexts and health literacy of your
patients. Create an encouraging,
blame-free environment. Talk openly
about expectations and goals.
Listen to their concerns. Answer their
questions.

• Use fixed-dose combination agents
when available
• Use medication adherence scales
to facilitate identification of barriers
• Recognize patients for achieving
treatment goals

15

Helpful Links and Other Resources
Here are some AHA tools and resources. They have been developed with guidance from
AHA volunteers who face the same challenges as you do and are sources you can trust.
2017 Hypertension Clinical Practice Guideline
Hypertension Highlights
Target BP: BP Improvement Program
Video Series: Clinical Strategies for the
2017 Hypertension Guidelines

Patient Resources
High Blood Pressure
Blood Pressure Fact Sheets

© Copyright 2019 American Heart Association, Inc., a 501(c)(3) not-for-profit. All rights reserved. Unauthorized use prohibited.
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Appendix B: Hypertension Knowledge Patient Pre and Post Questionnaire
Answer the following questions by circling one answer for each question.
1) If someone’s blood pressure is 130/80 it is
a) High
b) Low
c) Normal
d) Don’t know
2) If someone’s blood pressure is 160/100 it is
a) High
b) Low
c) Normal
d) Don’t know
3) Once someone has high blood pressure, it usually lasts for
a) A few years
b) 5-10 years
c) The rest of their life
d) Don’t know
4) People with high blood pressure should take their medication
a) Everyday
b) At least a few times a week
c) Only when they feel sick
5) Losing weight usually makes blood pressure
a) Go up
b) Go down
c) Stay the same
6) Eating less salt usually makes blood pressure
a) Go up
b) Go down
c) Stay the same
7) High blood pressure can cause heart attacks
a) Yes
b) No
c) Don’t know
8) High blood pressure can cause cancer
a) Yes
b) No
c) Don’t know
9) High blood pressure can cause kidney problems
a) Yes
b) No
c) Don’t know
10) High blood pressure can cause strokes
a) Yes
b) No
c) Don’t know
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ANSWERS

Lifestyle + Risk Reduction

High Blood Pressure

by heart

What is
High Blood
Pressure?
Blood pressure is the force of blood
pushing against blood vessel walls.
It is measured in millimeters of
mercury (mm Hg).
High blood pressure (HBP) means the
pressure in your arteries is higher than
it should be. Another name for high
blood pressure is hypertension.

BLOOD
PRESSURE
CATEGORY

SYSTOLIC
mm Hg
(upper number)

NORMAL

LESS THAN 120

and

LESS THAN 80

ELEVATED

120-129

and

LESS THAN 80

HIGH BLOOD
PRESSURE

130-139

or

80-89

140 OR HIGHER

or

90 OR HIGHER

HIGHER THAN 180

and/
or

HIGHER THAN 120

(HYPERTENSION)

DIASTOLIC
mm Hg
(lower number)

STAGE 1

HIGH BLOOD
PRESSURE

(HYPERTENSION)

STAGE 2

HYPERTENSIVE
CRISIS

(consult your doctor
immediately)

Blood pressure is written as two numbers, such
as 112/78 mm Hg. The top (systolic) number is
the pressure when the heart beats. The bottom
(diastolic) number is the pressure when the
heart rests between beats.
Normal blood pressure is below 120/80 mm Hg.
If you’re an adult and your systolic pressure is

Am I at higher risk of developing HBP?
There are risk factors that increase your chances of developing
HBP. Some you can control, and some you can’t.
Those that can be controlled are:
• Cigarette smoking and exposure to secondhand smoke

120 to 129, and your diastolic pressure is less

• Diabetes

than 80, you have elevated blood pressure.

• Being obese or overweight

High blood pressure is a systolic pressure of 130

• High cholesterol

or higher,or a diastolic pressure of 80 or higher,

• Unhealthy diet (high in sodium, low in potassium, and drinking
too much alcohol)

that stays high over time.
High blood pressure usually has no signs or

• Physical inactivity

symptoms. That’s why it is so dangerous. But it

Factors that can’t be modified or are difficult to control are:

can be managed.

• Family history of high blood pressure

Nearly half of the American population over

• Race/ethnicity

age 20, has HBP, and many don’t even know it.

• Increasing age

Not treating high blood pressure is dangerous.

• Gender (males)

High blood pressure increases the risk of heart

• Chronic kidney disease

attack and stroke.

• Obstructive sleep apnea

Make sure you get your blood pressure checked

Socioeconomic status and psychosocial stress are also risk factors
for HBP. These can affect access to basic living needs, medication,
health care providers, and the ability to adopt lifestyle changes.

regularly and treat it the way your health care
provider advises.

(continued)

What is High Blood Pressure?
How can I tell I have it?

What can I do about HBP?

The only way to know if you have high blood pressure is to
get it checked regularly by your health care provider.
For proper diagnosis of HBP, your health care provider will
use an average based on two or more readings obtained on
two or more visits.

• Don’t smoke and avoid secondhand smoke.
• Reach and maintain a healthy weight.
• Eat a healthy diet that is low in saturated and trans fats
and rich in fruits, vegetables, whole grains and low-fat
dairy products. Aim to consume less than 1,500 mg/day
of sodium (salt). Even reducing your daily intake by
1,000 mg can help.
• Eat foods rich in potassium. Aim for 3,500 – 5,000 mg of
dietary potassium per day.
• Limit alcohol to no more than one drink per day if you’re
a woman or two drinks a day if you’re a man.
• Be more physically active. Aim for 150 minutes of
moderate-intensity physical activity or at least 75
minutes of vigorous physical activity per week, or a
combination of both, spread throughout the week. Add
muscle-strengthening activity at least two days per week
for more health benefits.
• Take medicine the way your health care provider tells
you.
• Know what your blood pressure should be and work to
keep it at that level.

HOW CAN I LEARN MORE?
Call 1-800-AHA-USA1
(1-800-242-8721), or visit heart.org
to learn more about heart disease and
stroke.
Sign up to get Heart Insight, a free
e-newsletter for heart patients and
their families, at HeartInsight.org.
Connect with others sharing similar
journeys with heart disease and stroke
by joining our Support Network at
heart.org/SupportNetwork.

Do you have
questions for your
doctor or nurse?

MY QUEST ION S:

Take a few minutes
to write down your
questions for the next
time you see your
health care provider.
For example:
Will I always have to
take medicine?
What should my blood
pressure be?

We have many other fact sheets to help you make healthier choices to reduce your risk,
manage disease or care for a loved one. Visit heart.org/AnswersByHeart to learn more.
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My Blood Pressure Log
Name:
mm Hg

My Blood Pressure Goal:
Instructions:
•

Measure your blood pressure twice a day—morning and late afternoon—at about the same times every day.

•

For best results, sit comfortably with both feet on the floor for at least two minutes before taking a measurement.

•

When you measure your blood pressure, rest your arm on a table so the blood pressure cuff is at about the same height as
your heart.

•

Record your blood pressure on this sheet and show it to your doctor at every visit.

•

You can also use AHA’s Check. Change. Control.® Tracker (ccctracker.com/aha), a free online tool to help you track and
monitor your blood pressure. Just find the campaign code on the map for your state and sign up.

DATE

AM

PM

DATE

AM

PM
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What Can I Do To Improve My Blood Pressure?
Modification

Recommendation

Approximate SBP
Reduction Range

Weight reduction

Maintain normal body weight
(BMI=18.5-24.9 kg/m2)

5 mm Hg

DASH eating plan

Diet rich in fruits, vegetables, low
fat dairy and reduced in fat

11 mm Hg

Restrict sodium
intake

<1500 mg of sodium per day

5-6 mm Hg

Physical activity

Be more physically active.
Aim for at least 90 to 150 minutes
of aerobic exercise per week.

5-8 mm Hg

Moderation of
alcohol consumption

No more than
2 drinks/day for men and
1 drink/day for women

4 mm Hg

BP = Blood pressure, BMI = Body mass index, SBP = Systolic blood pressure, DASH = Dietary Approaches to Stop Hypertension

Ranges According to 2017 Hypertension Clinical Practice Guidelines
Recommendations for Treatment and Management of Hypertension

Consequences of High Blood Pressure
High blood pressure is often the first domino in a chain or “domino effect”
leading to devastating consequences, like:

STROKE
HBP can cause blood vessels
in the brain to burst or clog
more easily.

HEART FAILURE
HBP can cause the heart to
enlarge and fail to supply
blood to the body.

VISION LOSS
HBP can strain the
vessels in the eyes.

HEART ATTACK
HBP damages arteries that
can become blocked.

KIDNEY DISEASE/
FAILURE

SEXUAL
DYSFUNCTION
This can be erectile
dysfunction in men or
lower libido in women.

A simple blood pressure check is the first step
to preventing the “domino effect.” 
Learn more at heart.org/hbp.
© Copyright 2020 American Heart Association, Inc., a 501(c)(3) not-for-profit.
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HBP can damage the
arteries around the kidneys
and interfere with their
ability to effectively filter
blood.
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July

X

June

X

May

X

April

X
X

March

X

February

IRB approval
Recruitment
of eligible
participants
Prequestionnaire
, Intervention,
and Post
Questionnaire
3 Month PostQuestionnaire
and Analysis
of Outcomes
Presentation
of results

January

X

December

PERC
approval

November

October

Task
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